{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:58:03Z","timestamp":1761742683776,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.arcmed.2005.05.013","type":"journal-article","created":{"date-parts":[[2005,11,29]],"date-time":"2005-11-29T07:42:00Z","timestamp":1133250120000},"page":"129-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Hypertriglyceridemia and Hypercholesterolemia in Human Immunodeficiency Virus-1-Infected Children Treated with Protease Inhibitors"],"prefix":"10.1016","volume":"37","author":[{"given":"Fortino","family":"Sol\u00f3rzano Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura G.","family":"Gochicoa Rangel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo","family":"Palacios Saucedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"V\u00e1zquez Rosales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Guadalupe","family":"Miranda Novales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2005.05.013_bib1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00002030-199806000-00011","article-title":"The antiviral effect of ritonavir and saquinavir in combination amongst HIV-infected adults: results from a community-based study","volume":"12","author":"Rhone","year":"1998","journal-title":"AIDS"},{"issue":"RR\u20135","key":"10.1016\/j.arcmed.2005.05.013_bib2","first-page":"43","article-title":"Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents","volume":"47","year":"1998","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.arcmed.2005.05.013_bib3","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/00006454-199808000-00013","article-title":"Early experience with protease inhibitors in human immunodeficiency virus-infected children","volume":"17","author":"Saez-Llorens","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.arcmed.2005.05.013_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00002030-200301240-00008","article-title":"Differentiating hyperlipidemia associated with antiretroviral therapy","volume":"17","author":"Mauss","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.arcmed.2005.05.013_bib5","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-199907090-00001","article-title":"Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patient under treatment with protease inhibitors","volume":"13","author":"Behrens","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.arcmed.2005.05.013_bib6","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/archinte.160.13.2050","article-title":"Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study","volume":"160","author":"Tsiodras","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.arcmed.2005.05.013_bib7","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/00002030-199811000-00024","article-title":"Marked hypertriglyceridemia associated with ritonavir therapy","volume":"2","author":"Sullivan","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.arcmed.2005.05.013_bib8","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1097\/00002030-199815000-00024","article-title":"Is treatment with ritonavir a risk factor for myocardial infarction in HIV-infected patients?","volume":"12","author":"Eriksson","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.arcmed.2005.05.013_bib9","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/S0140-6736(98)26026-0","article-title":"Vascular complications associated with use of HIV protease inhibitors","volume":"351","author":"Behrens","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2005.05.013_bib10","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1046\/j.1525-1497.2002.20201.x","article-title":"Evaluation and management of dyslipidemia in patients with HIV infection","volume":"17","author":"Green","year":"2002","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.arcmed.2005.05.013_bib11","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1097\/00002030-199911120-00020","article-title":"Visceral obesity, hypertriglyceridemia, and hypercortisolism in a boy with perinatally acquired HIV infection receiving protease inhibitor-containing antiviral treatment","volume":"13","author":"Arpadi","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.arcmed.2005.05.013_bib12","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1097\/00002030-200009290-00008","article-title":"Clinical and metabolic presentation of lipodystrophic syndrome in HIV-infected children","volume":"14","author":"Jaquet","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.arcmed.2005.05.013_bib13","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(98)05754-7","article-title":"Abnormal body fat distribution in HIV-1 infected children on antiretrovirals","volume":"353","author":"Babl","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2005.05.013_bib14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00006454-200205000-00011","article-title":"Lipodystrophy syndrome in human immunodeficiency virus-infected children","volume":"21","author":"Amaya","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.arcmed.2005.05.013_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/00365540110077047","article-title":"Response to two consecutive protease inhibitors combination therapy regimens in a cohort of HIV-1-infected children","volume":"34","author":"Palacios","year":"2002","journal-title":"Scand J Infect Dis"},{"issue":"RR12","key":"10.1016\/j.arcmed.2005.05.013_bib16","first-page":"1","article-title":"1994 revised classification system for human immunodeficiency virus infection in children <13 years of age","volume":"43","author":"Centers for Disease Control and Prevention","year":"1994","journal-title":"MMWR"},{"key":"10.1016\/j.arcmed.2005.05.013_bib17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1542\/pir.17.3.94","article-title":"Evaluation of hypercholesterolemia in childhood","volume":"17","author":"Starc","year":"1996","journal-title":"Pediatr Rev"},{"year":"2000","series-title":"The Harriet Lane Handbook","author":"Siberry","key":"10.1016\/j.arcmed.2005.05.013_bib18"},{"key":"10.1016\/j.arcmed.2005.05.013_bib19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1620\/tjem.201.75","article-title":"Serum cholesterol, triglyceride, VLDL-c, LDL-c and HDL-c levels in healthy children","volume":"201","author":"Bahar","year":"2003","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.arcmed.2005.05.013_bib20","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1345\/aph.18174","article-title":"Hyperlipidemia associated with protease inhibitor therapy","volume":"33","author":"Echevarria","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.arcmed.2005.05.013_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1053\/jinf.2001.0829","article-title":"Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate","volume":"42","author":"Manfredi","year":"2001","journal-title":"J Infect"},{"key":"10.1016\/j.arcmed.2005.05.013_bib22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/003655401300077388","article-title":"Comparison of P-triglyceride levels among patients with human immunodeficiency virus on randomized treatment with ritonavir, indinavir or ritonavir\/saquinavir","volume":"33","author":"Roge","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.arcmed.2005.05.013_bib23","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/01.ATV.20.12.2625","article-title":"HIV protease inhibitors stimulate hepatic triglyceride synthesis","volume":"20","author":"Lenhard","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.arcmed.2005.05.013_bib24","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1097\/00002030-199912240-00002","article-title":"Fat distribution and metabolic changes in patients with HIV infection","volume":"13","author":"Safrin","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.arcmed.2005.05.013_bib25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00041433-200106000-00011","article-title":"Antiretroviral therapy-associated hyperlipidemia in HIV disease","volume":"12","author":"Mooser","year":"2001","journal-title":"Curr Opin Lipidol"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440905002365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440905002365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:30:32Z","timestamp":1759260632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440905002365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0188440905002365"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2005.05.013","relation":{},"ISSN":["0188-4409"],"issn-type":[{"type":"print","value":"0188-4409"}],"subject":[],"published":{"date-parts":[[2006,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertriglyceridemia and Hypercholesterolemia in Human Immunodeficiency Virus-1-Infected Children Treated with Protease Inhibitors","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2005.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}